Lixia Sheng
-
- Acute Myeloid Leukemia Research 12
- Multiple Myeloma Research and Treatments 3
-
- MicroRNA in disease regulation 3
-
- Chronic Lymphocytic Leukemia Research 4
-
- Lymphoma Diagnosis and Treatment 13
-
- Immune Cell Function and Interaction 8
-
- Viral-associated cancers and disorders 5
-
- Retinoids in leukemia and cellular processes 4
- Cited by
- HematologyCancer ResearchGenetics
- Partner nations
- ChinaUnited States
In The Last Decade
Lixia Sheng
43 papers receiving 251 citations
Peers
Comparison fields: 5 of 62
- Hematology 54
- Cancer Research 54
- Genetics 31
- Pathology and Forensic Medicine 38
- Surfaces, Coatings and Films 14
Countries citing papers authored by Lixia Sheng
This map shows the geographic impact of Lixia Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Sheng more than expected).
Fields of papers citing papers by Lixia Sheng
This network shows the impact of papers produced by Lixia Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Sheng. The network helps show where Lixia Sheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lixia Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 18 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 1 | |
| 13 | 2021 | 9 | |
| 14 | 2021 | 6 | |
| 15 | 2021 | 9 | |
| 16 | 2020 | 29 | |
| 17 | 2020 | 17 | |
| 18 | 2019 | 8 | |
| 19 | 2018 | 11 | |
| 20 | 2018 | 6 |
About Lixia Sheng
Lixia Sheng is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 50 papers that have together received 253 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (12 papers), Immune Cell Function and Interaction (8 papers), Viral-associated cancers and disorders (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Retinoids in leukemia and cellular processes (4 papers), Multiple Myeloma Research and Treatments (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Hematology (54 citations), Cancer Research (54 citations) and Genetics (31 citations). Lixia Sheng has collaborated with scholars based in China and United States. Frequent co-authors include Guifang Ouyang, Qitian Mu, Miao Zhou, He Huang, Binbin Lai, Ye Sun, Kaihong Xu, Jiaping Wang, Yanli Zhang and Bixia Li. Their work appears in journals such as Blood, Frontiers in Immunology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.